Results 271 to 280 of about 999,769 (295)

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

American Journal of Respiratory and Critical Care Medicine, 2018
Background: This document provides clinical recommendations for the diagnosis of idiopathic pulmonary fibrosis (IPF). It represents a collaborative effort between the American Thoracic Society, European Respiratory Society, Japanese Respiratory Society ...
David Lederer, Ella Kazerooni, Sudhakar Pipavath   +2 more
exaly   +2 more sources

Idiopathic Pulmonary Fibrosis

New England Journal of Medicine, 2018
David Lederer, Fernando Martinez
exaly   +2 more sources

Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis.

Annual Review of Pathology, 2021
The pathogenesis of idiopathic pulmonary fibrosis (IPF) involves a complex interplay of cell types and signaling pathways. Recurrent alveolar epithelial cell (AEC) injury may occur in the context of predisposing factors (e.g., genetic, environmental ...
B. Moss, S. Ryter, I. Rosas
semanticscholar   +1 more source

Idiopathic pulmonary fibrosis: state of the art for 2023

European Respiratory Journal, 2023
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease characterised by worsening respiratory symptoms and physiological impairment.
A. Podolanczuk, C. Thomson, M. Rémy-Jardin, L. Richeldi, F. Martinez, M. Kolb, G. Raghu   +6 more
semanticscholar   +1 more source

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Yearbook of Pulmonary Disease, 2015
Proteomic Profiling Reveals Autoimmune Targets in Sarcoidosis. 5 Cardiac Positron Emission Tomography Enhances Prognostic Assessments of Patients with Suspected Cardiac Sarcoidosis.
C. D. Spradley
semanticscholar   +1 more source

Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe

Respirology (Carlton South. Print), 2022
There remains a paucity of large databases for patients with idiopathic pulmonary fibrosis (IPF) and lung cancer. We aimed to create a European registry.
T. Karampitsakos, P. Spagnolo, N. Mogulkoc, W. Wuyts, S. Tomassetti, E. Bendstrup, M. Molina-Molina, E. Manali, Ö. S. Unat, F. Bonella, N. Kahn, L. Kolilekas, E. Rosi, L. Gori, C. Ravaglia, V. Poletti, Z. Daniil, T. Prior, I. Papanikolaou, S. Aso, S. Tryfon, D. Papakosta, V. Tzilas, E. Balestro, S. Papiris, K. Antoniou, Demosthenes Bouros, A. Wells, M. Kreuter, A. Tzouvelekis   +29 more
semanticscholar   +1 more source

An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

, 2012
M. R. D. de Christenson
semanticscholar   +1 more source

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.

American Journal of Respiratory and Critical Care Medicine, 2015
G. Raghu, B. Rochwerg, Y. Zhang, C. C. Cuello Garcia, Azuma Arata, J. Behr, J. Brożek, H. Collard, W. Cunningham, S. Homma, T. Johkoh, F. Martinez, J. Myers, Shandra L. Protzko, L. Richeldi, D. Rind, M. Selman, A. Theodore, A. Wells, H. Hoogsteden, H. Schünemann   +20 more
semanticscholar   +1 more source

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.

The Lancet, 2011
P. Noble, C. Albera, W. Bradford, U. Costabel, M. Glassberg, D. Kardatzke, T. King, L. Lancaster, S. Sahn, J. Szwarcberg, D. Valeyre, R. D. du Bois   +11 more
semanticscholar   +1 more source

Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement

, 2000
J. King, U. Costabel, J. Cordier, G. Dopico, R. Dubois, D. Lynch, J. Lynch, J. Myers, R. Panos, G. Raghu, D. Schwartz, C. M. Smith   +11 more
semanticscholar   +1 more source